Kathleen Richter, PhD

Alvotech
Jülich, Germany

46

Disclosure information not submitted.

Presentation(s):

• 0809: Ex Vivo Comparative Immunogenicity Assessment (EVCIA) to Determine Relative Immunogenicity in Chronic Plaque Psoriasis in Participants Receiving Humira® or Undergoing Repeated Switches Between Humira and AVT02

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time